Electroencephalographic findings with low-dose clozapine treatment in psychotic parkinsonian patients

Clinical Neuropharmacology

Volumn 19, Issue 1, 1996, Pages 81-86

  Neufeld, M Y ^a,b   Rabey, J M ^a   Orlov, E ^a   Korczyn, A D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Clozapine; Electroencephalography; Epileptic activity; Parkinson's disease; Psychosis; Seizures

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CARBIDOPA; CHLORPROMAZINE; CLOZAPINE; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; FEMALE; HALLUCINATION; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE;

EID: 0030049703     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619010-00007     Document Type: Article

References (16)

1. 4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;324:746-54.
2. Anderson PH, Braestrup C. Evidence for different states of dopamine D, receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase coupled state of the D, receptor. J Neurochem 1986;47:1822-31.
3. Baldessarini RJ, Frankenburg FR. Drug therapy: clozapine - a novel antipsychotic agent. N Engl J Med 1991;324:746-54.
4. Wolters ECh, Hurwitz TA, Mak A, et al. Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis. Neurology 1990;40:832-4.
5. Liberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989;50:329-38.
6. Tiihonen J, Nousiainen U, Hakola P, et al. EEG abnormalities associated with clozapine treatment. Am J Psychiatry 1991;148:1406.
7. Rabey JM, Orlov E, Katz T, Korczyn AD. Beneficial effect of low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease [Abstract]. Neurology 1994;44 (suppl):245.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington, DC: American Psychiatric Press, 1987.
10. Mayo Clinic and Mayo Foundation. Electroencephalography. In: Members of the Departments of Neurology and of Physiology and Biophysics, Mayo Clinic and Mayo Foundation for Medical Education and Research, eds. Clinical examinations in neurology. Philadelphia: WB Saunders, 1976:275-97.
11. Itil TM. Effects of psychotropic drugs in qualitatively and quantitatively analyzed human EEG. In: Clark WG, del Guidice J, eds. Principles of psychopharamacology. 2nd ed. New York: Academic Press, 1978:261-77.
12. Logothetis J. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology 1967;17:869-77.
13. Haller E, Binder R. Clozapine and seizures. Am J Psychiatry 1947;8:1069-71.
14. Devinsky O, Honigfeld G. Patin J. Clozapine-related seizures. Neurology 1991;41:369-71.
15. Gunther W. Baghai T, Naber D, Spatz R, Hippius H. EEC alterations and seizures during treatment with clozapine. A retrospective study of 283 patients. Pharmacopsychiatry 1993;26:69-74.
16. Pfeiffer RF, Rang J, Graber B, Hofman R, Wilson J. Clozapine in psychosis in Parkinson's disease. Mov Disord 1990;5:239-42.